More than 20 leading UK health tech innovators are heading to Texas this week to boost export opportunities as part of the first major trade visit organised by the Association of British HealthTech Industries (ABHI) for its new class of ABHI US Accelerator companies.
Taking place from March 26-31, the Texas visit will see members participate in a series of meetings, networking events and introductions across Austin, El Paso and San Antonio to promote the excellence of the UK’s health technology industry.
Throughout the week, the cohort of UK companies – comprising some of the UK’s most forward-thinking health tech innovators – will be showcasing a range of ground-breaking products and solutions to the US market.
Meetings will take place with senior leadership from hospital systems – including HCA Healthcare, Baptist Health and Optum – group purchasing organisations (GPOs), investors, distributors and procurement teams.
The visit will also incorporate a series of group meetings, networking events, working groups and introductions to various supporting organisations such as the El Paso Chamber of Commerce and BioMedSA.
Paul Benton, Managing Director, International, said:
“As home to some of the country’s largest healthcare providers, Texas offers substantial opportunities to UK companies and is the perfect springboard for them to access the wider US market.
“Our visit targets senior leaders across many of the main hospital systems in the State and offers unprecedented access to key decision makers and leaders.”
With a series of innovation partners based in the US, the ABHI US Accelerator is once again working with the Dell Medical School, one of the United States’ most pioneering academic institutions, based at the University of Texas, in Austin.
Through key in-market partners like Dell, the programme offers nationwide support, drawing on the relationships and connections built up across the country.
Texas has the second largest GDP of any US State at 1.7 trillion dollars and were it a sovereign country, would be ranked as the 12th largest economy in the world by GDP.
“We are excited to be heading back to Texas with a delegation of some of the UK’s most remarkable health technology companies and look forward to supporting them in their goals to explore collaborative opportunities and strengthen trade.”
A total of 20 companies from the world of health tech are taking part in this year’s cohort, comprising a diverse mix of medical device, diagnostics and digital health businesses, several of which are long-standing members of the programme, along with a host of new entrants.
Over the course of the year, participants will enjoy exclusive week-long trade visits across the US, providing them with prime opportunities to engage with key stakeholders for their individual company objectives and present proven UK health tech to new clients.
The first call for the new class of ABHI US Accelerator companies will take place in Austin, San Antonio and El Paso, followed by visits to Tennessee, California, and Florida later in the year.
The programme for this year’s ABHI US Accelerator is sponsored by leading international legal firm DAC Beachcroft (DACB), Healthcare Innovation Consortium (HIC) – a digital health and social care agency committed to advancing innovation in healthcare – and leading legal and business consulting firm, Wilson Sonsini.
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI6 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds